Thank you for using the timer!
We noticed you are actually not timing your practice. Click the START button first next time you use the timer.
There are many benefits to timing your practice, including:
Re: Wall St Series (IB/PE etc) - Latest Trend [#permalink]
23 Mar 2009, 07:14
UBS extends lock-in for directors’ incentives to eight years
UBS directors will in future be locked into equity incentive plans for up to eight years, as part of an initiative by the Swiss bank to improve its governance. Until now, executives could sell vested stock after five years, as long as they continued to own equity valued at five times their cash compensation.
UBS also intends to gain the right to cut cash incentives promised up to three years earlier. The principles behind this system will also be applied to risk-takers, including traders, operating at a senior level below the board. Notice periods will be halved to six months.
Kellogg Class of 2010...still active and willing to help. However, I do not do profile reviews, don't offer predictions on chances and am far to busy to review essays, so save the energy of writing me a PM seeking help for these. If I don't respond to a PM that is not one of the previously mentioned trash can destined messages, please don't take it personally I get so many messages I have a hard to responding to most. The more interesting, compelling, or humorous you message the more likely I am to respond.
Re: If Goldman Returns Aid, Will Others? [#permalink]
23 Mar 2009, 18:41
If Goldman Returns Aid, Will Others?
Goldman Sachs is planning to return the TARP money due to the compensation restriction issues (among other things). Other banks want to follow. However, are the banks really strong enough to give up this money? Is this a sign that the value of all their toxic securities hit the bottom and they won't be devalued anymore?
Re: Wall Street Deal Making Enters Stealth Mode [#permalink]
25 Mar 2009, 13:09
Wall Street Deal Making Enters Stealth Mode
After months of constricted options and volatile markets, the wide world of deals is looking up again.
U.S. companies are testing the markets with select mergers, initial public offerings, follow-on equity offerings and debt sales after the deep freeze of 2008. Some have even sought multiple deals–Alcoa’s $1.3 billion sale of stock and convertible bonds, say, or swiss pharmaceutical company Nycomed hiring Goldman Sachs Group to explore either a merger or an initial public offering so that Nycomed’s investors, Scandinavia’s Nordic Capital and Swiss-owned Credit Suisse DLJ Merchant Banking Partners, can cash out on part of their investment. An IPO is not likely, but even the idea that it is on the table is meaningful.